What is Fullscript?
Founded in 2011 by Kyle Braatz, Brad Dyment, and Chris Wise, Fullscript has established itself as a critical digital dispensing platform for nutritional supplements. By bridging the gap between healthcare practitioners and patients, the company facilitates a seamless, evidence-based approach to supplement management. Its platform serves as a vital utility for clinicians in the United States and Canada, ensuring that patients receive high-quality, practitioner-grade products through a streamlined digital interface. As the health-tech landscape evolves, Fullscript remains at the forefront of integrating clinical care with e-commerce efficiency.
How much funding has Fullscript raised?
Fullscript has raised a total of $290M across 3 funding rounds:
Series A
$25M
Series B
$25M
Unspecified
$240M
Series A (2019): $25M with participation from Kayne Partners
Series B (2019): $25M led by Kayne Anderson Capital Advisors
Unspecified (2021): $240M supported by HGGC and Snapdragon Capital Partners
Key Investors in Fullscript
Kayne Partners
Kayne Anderson Capital Advisors, L.P. is an alternative investment management firm with a focus on energy, infrastructure, real estate, credit, and growth equity.
HGGC
HGGC is a middle-market private equity firm based in Palo Alto, California, offering platform investments, add-on acquisitions, and recapitalization services.
Snapdragon Capital Partners
Snapdragon Capital Partners is a growth equity firm that partners with companies in the consumer sector, particularly focusing on Health & Wellness brands and Health Services.
What's next for Fullscript?
With the recent influx of capital, Fullscript is well-positioned to accelerate its market penetration and enhance its technological capabilities. The strategic focus will likely center on expanding its practitioner network and deepening its integration with electronic health records to provide a more cohesive patient experience. By leveraging the expertise of its growth-oriented investors, the company is poised to solidify its leadership in the digital health space, potentially exploring new product categories or international markets. The current enterprise-level funding provides the necessary runway to innovate within the competitive wellness technology ecosystem, ensuring that Fullscript remains the preferred partner for practitioners seeking to optimize patient outcomes through digital health solutions.
See full Fullscript company page
